IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-37573-y.html
   My bibliography  Save this article

A host defense peptide mimetic, brilacidin, potentiates caspofungin antifungal activity against human pathogenic fungi

Author

Listed:
  • Thaila Fernanda Reis

    (Universidade de São Paulo)

  • Patrícia Alves Castro

    (Universidade de São Paulo)

  • Rafael Wesley Bastos

    (Universidade de São Paulo)

  • Camila Figueiredo Pinzan

    (Universidade de São Paulo)

  • Pedro F. N. Souza

    (Federal University of Ceará)

  • Suzanne Ackloo

    (University of Toronto)

  • Mohammad Anwar Hossain

    (University of North Carolina at Chapel Hill)

  • David Harold Drewry

    (University of North Carolina at Chapel Hill
    University of North Carolina at Chapel Hill)

  • Sondus Alkhazraji

    (The Lundquist Institute for Biomedical Innovation at Harbor-University of California Los Angeles (UCLA) Medical Center)

  • Ashraf S. Ibrahim

    (The Lundquist Institute for Biomedical Innovation at Harbor-University of California Los Angeles (UCLA) Medical Center
    David Geffen School of Medicine at UCLA)

  • Hyunil Jo

    (University of California, San Francisco)

  • Jorge D. Lightfoot

    (University of Oklahoma Health Sciences Center)

  • Emily M. Adams

    (University of Oklahoma Health Sciences Center)

  • Kevin K. Fuller

    (University of Oklahoma Health Sciences Center
    Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center)

  • William F. deGrado

    (University of California, San Francisco)

  • Gustavo H. Goldman

    (Universidade de São Paulo)

Abstract

Fungal infections cause more than 1.5 million deaths a year. Due to emerging antifungal drug resistance, novel strategies are urgently needed to combat life-threatening fungal diseases. Here, we identify the host defense peptide mimetic, brilacidin (BRI) as a synergizer with caspofungin (CAS) against CAS-sensitive and CAS-resistant isolates of Aspergillus fumigatus, Candida albicans, C. auris, and CAS-intrinsically resistant Cryptococcus neoformans. BRI also potentiates azoles against A. fumigatus and several Mucorales fungi. BRI acts in A. fumigatus by affecting cell wall integrity pathway and cell membrane potential. BRI combined with CAS significantly clears A. fumigatus lung infection in an immunosuppressed murine model of invasive pulmonary aspergillosis. BRI alone also decreases A. fumigatus fungal burden and ablates disease development in a murine model of fungal keratitis. Our results indicate that combinations of BRI and antifungal drugs in clinical use are likely to improve the treatment outcome of aspergillosis and other fungal infections.

Suggested Citation

  • Thaila Fernanda Reis & Patrícia Alves Castro & Rafael Wesley Bastos & Camila Figueiredo Pinzan & Pedro F. N. Souza & Suzanne Ackloo & Mohammad Anwar Hossain & David Harold Drewry & Sondus Alkhazraji &, 2023. "A host defense peptide mimetic, brilacidin, potentiates caspofungin antifungal activity against human pathogenic fungi," Nature Communications, Nature, vol. 14(1), pages 1-19, December.
    • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-37573-y
    DOI: 10.1038/s41467-023-37573-y
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-37573-y
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-023-37573-y?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Kali R. Iyer & Kaddy Camara & Martin Daniel-Ivad & Richard Trilles & Sheila M. Pimentel-Elardo & Jen L. Fossen & Karen Marchillo & Zhongle Liu & Shakti Singh & José F. Muñoz & Sang Hu Kim & John A. Po, 2020. "An oxindole efflux inhibitor potentiates azoles and impairs virulence in the fungal pathogen Candida auris," Nature Communications, Nature, vol. 11(1), pages 1-17, December.
    2. Janette Reader & Mariëtte E. van der Watt & Dale Taylor & Claire Le Manach & Nimisha Mittal & Sabine Ottilie & Anjo Theron & Phanankosi Moyo & Erica Erlank & Luisa Nardini & Nelius Venter & Sonja Laut, 2021. "Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box," Nature Communications, Nature, vol. 12(1), pages 1-15, December.
    3. Nicola Nosengo, 2016. "Can you teach old drugs new tricks?," Nature, Nature, vol. 534(7607), pages 314-316, June.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Shin, Hyunjin & Woo, Hyun Goo & Sohn, Kyung-Ah & Lee, Sungjoo, 2023. "Comparing research trends with patenting activities in the biomedical sector: The case of dementia," Technological Forecasting and Social Change, Elsevier, vol. 195(C).
    2. Kouichi Hosomi & Mai Fujimoto & Kazutaka Ushio & Lili Mao & Juran Kato & Mitsutaka Takada, 2018. "An integrative approach using real-world data to identify alternative therapeutic uses of existing drugs," PLOS ONE, Public Library of Science, vol. 13(10), pages 1-19, October.
    3. Mariska Naude & Ashleigh van Heerden & Janette Reader & Mariëtte van der Watt & Jandeli Niemand & Dorè Joubert & Giulia Siciliano & Pietro Alano & Mathew Njoroge & Kelly Chibale & Esperanza Herreros &, 2024. "Eliminating malaria transmission requires targeting immature and mature gametocytes through lipoidal uptake of antimalarials," Nature Communications, Nature, vol. 15(1), pages 1-15, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-37573-y. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.